Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies. J of Skin. 2017;1(3.1):s130. doi:10.25251/skin.1.supp.129